Research finds increased heart attack risk among antipsychotic users
May 18, 2016
People who take antipsychotic medications may be at increased risk for heart attacks, according to a new study.
Affinity Living tests light’s effects on residents living with dementia
Jun 24, 2019
New studies by Affinity Living Group and the University of North Carolina Chapel Hill aim to use light to reduce the number of falls or amount of agitation in residents living with dementia.
$625,000 stipend will continue work to alter perceptions of aging, dementia
By
Lois A. Bowers
Oct 05, 2016
Anne Basting’s work to improve older adults’ quality of life and change perceptions related to aging and dementia recently received a big boost in the form of a $625,000 “genius grant”...
Anticholinergic drugs don’t raise dementia risk in those with Parkinson’s
By
Lois A. Bowers
Jan 05, 2016
Concern that anticholinergic drugs could potentially worsen cognition in those with Parkinson’s disease are unfounded, according to new research reported in the Journal of Parkinson’s Disease.
More news for Tuesday, March 1
By
Kimberly Bonvissuto
Mar 01, 2022
NHI, Welltower work toward settlement regarding Holiday Retirement properties … Proclamation lifts some restrictions for Washington state assisted living communities … State drops case against nurse...
More news for Tuesday, Aug. 30
By
Kimberly Bonvissuto
Aug 30, 2022
NCOA, CDC Foundation launch online tool to help older adults assess their fall risk … Nurse steals $2K from 97-year-old resident for pizza party for son, police say … Economic instability, loneliness,...
Dementia care managers in CCRCs see 2.75% bump in pay, survey says
By
Lois A. Bowers
Jul 12, 2018
Memory care unit managers in continuing care retirement communities, also known as life plan communities, saw an average pay increase of 2.75% in 2018, according to the “Continuing Care Retirement...
Alzheimer’s funding at NIH could top $1 billion
By
Lois A. Bowers
Jun 06, 2016
A $400 million increase in Alzheimer’s funding proposed Monday by a Senate Appropriations subcommittee, if approved, would put federal funding for the disease to the National Institutes of Health...
Ethical considerations explored for aducanumab in Alzheimer’s disease
Nov 19, 2021
Grounds are insufficient to offer aducanumab (Aduhelm) for moderate, advanced Alzheimer’s dementia or for individuals without biomarker evidence of brain ß-amyloid, according to a position statement.
Creating a new ‘environment’
By
John Andrews
Dec 01, 2016
Through experiential memory care, residents receive a multi-sensory experience designed to create an optimum level of well-being.